Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06752733
NCT06752733
Active, not recruiting
Not Applicable

The Association Between Myocardial Stunning and Long-term Prognosis After Electrical Cardioversion in Patients with Atrial Fibrillation

Korea University Guro Hospital1 site in 1 country160 target enrollmentFebruary 20, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAtrial Fibrillation (AF)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation (AF)
Sponsor
Korea University Guro Hospital
Enrollment
160
Locations
1
Primary Endpoint
The recurrence of atrial arrhythmia
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The goal of this observational study is to evaluate cardiac stunning and electrocardiographic parameters through transthoracic echocardiography and 24 hours ECG conducted immediately following electrical cardioversion. The main question it aims to answer is:

Do echocardiographic and electrocardiographic parameters relating to cardiac stunning predict atrial fibrillation (AF) recurrence rates after electrical cardioversion?

Participants will undergo echocardiography and a 24-hour Holter monitoring immediately after electrical cardioversion.

Registry
clinicaltrials.gov
Start Date
February 20, 2024
End Date
August 31, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Roh Seung Young

Professor

Korea University Guro Hospital

Eligibility Criteria

Inclusion Criteria

  • •Patients with atrial fibrillation
  • •Patients with persistent or symptomatic atrial fibrillation who are candidates for electrical cardioversion
  • •Patients eligible for anticoagulation therapy for thromboembolism prevention before and after the procedure
  • •Patients who can understand and provide written informed consent

Exclusion Criteria

  • •Patients under 18 years of age or over 80 years of age
  • •Patients who do not consent to participate in the study
  • •Patients with severe coronary artery stenosis
  • •Patients with severe hepatic dysfunction
  • •Patients with severe renal dysfunction
  • •Patients with severe valvular heart disease
  • •Patients with a high risk of severe bleeding
  • •Patients with a history of atrial fibrillation-related catheter ablation or cardiac surgery
  • •Patients with an expected life expectancy of less than 1 year
  • •Potentially pregnant individuals

Outcomes

Primary Outcomes

The recurrence of atrial arrhythmia

Time Frame: From enrollment to the end of treatment at 12 months

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-HospitalChronic Obstructive Pulmonary DiseaseTakotsubo CardiomyopathyAcute Heart Failure
NCT06597331Sahlgrenska University Hospital200
Not yet recruiting
Not Applicable
The Relationship Between Myocardial Blush Grade and T-P-e Interval and QRS Width: Impact on In-Hospital Outcome After Successful Primary Percutaneous Coronary InterventionMyocardial Infarction
NCT05593822Assiut University80
Not yet recruiting
Not Applicable
Association between electrocardiographic strain, angina, and systolic longitudinal left ventricular (LV) function in patients with severe aortic valve stenosis (AS).
NL-OMON26907Erasmus MC Dept. cardio-thoracic Surgery122
Completed
Not Applicable
Study of Myocardial Function by Speckle Tracking After Cancer Treatment With Anthracyclines in ChildhoodMyocardial FunctionEchographic Parameters Obtaind by Speckle TrackingChilhood Cancers
NCT02893787University Hospital, Montpellier196
Completed
Not Applicable
Analysis of blood flow in the aorta and heart structure in heart and blood vessels diseases using magnetic resonance imaging
ISRCTN14567789Charité - University Medicine Berlin150